Sign in

CIK 0000914475 · Large accelerated filer

NEUROCRINE BIOSCIENCES INC

Sign in to watch
Ticker
NBIX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
330525145
Phone
(858) 617-7600
Business address
6027 EDGEWOOD BEND COURT, SAN DIEGO, CA, 92130
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,162,347
in 4 filings, $3.2M under 10b5-1 plans

Net −$3,162,347. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-02-13 Gano Kyle Chief Executive Officer Grant or award · Restricted Stock Unit +20,142 20,142
2026-02-13 Lippoldt Darin Chief Legal Officer Option exercise +2,017 50,634
2026-02-13 Lippoldt Darin Chief Legal Officer Shares withheld for taxes −1,089 $124.12 $135K 49,545
2026-02-13 Lippoldt Darin Chief Legal Officer Option exercise +2,083 51,628
2026-02-13 Lippoldt Darin Chief Legal Officer Shares withheld for taxes −1,124 $124.12 $140K 50,504
2026-02-13 Lippoldt Darin Chief Legal Officer Grant or award +9,968 60,472
2026-02-13 Lippoldt Darin Chief Legal Officer Shares withheld for taxes −5,378 $124.12 $668K 55,094
2026-02-13 Lippoldt Darin Chief Legal Officer Gift −365 54,729
2026-02-13 Lippoldt Darin Chief Legal Officer Option exercise · Restricted Stock Unit −2,017 4,036
2026-02-13 Lippoldt Darin Chief Legal Officer Option exercise · Restricted Stock Unit −2,083 2,083
2026-02-13 Lippoldt Darin Chief Legal Officer Grant or award · Stock Option +34,909 34,909
2026-02-13 Lippoldt Darin Chief Legal Officer Grant or award · Restricted Stock Unit +6,124 6,124
2026-02-13 GORMAN KEVIN CHARLES Director Option exercise +5,604 522,497
2026-02-13 GORMAN KEVIN CHARLES Director Shares withheld for taxes −3,024 $124.12 $375K 519,473
2026-02-13 GORMAN KEVIN CHARLES Director Option exercise +5,377 524,850
2026-02-13 GORMAN KEVIN CHARLES Director Shares withheld for taxes −2,901 $124.12 $360K 521,949
2026-02-13 GORMAN KEVIN CHARLES Director Grant or award +63,724 585,673
2026-02-13 GORMAN KEVIN CHARLES Director Shares withheld for taxes −34,380 $124.12 $4.3M 551,293
2026-02-13 GORMAN KEVIN CHARLES Director Option exercise · Restricted Stock Unit −5,604 11,208
2026-02-13 GORMAN KEVIN CHARLES Director Option exercise · Restricted Stock Unit −5,377 5,377

Page 12 of 49 · 963 trades